In the UK, as I understand it, we have: MHRA: approval for marketing and sale within the UK NICE: analyse cost/benefit ratio and safety profile for use within

In the UK, as I understand it, we have: MHRA: approval for marketing and sale within the UK NICE: analyse cost/benefit ratio and safety profile for use within NHS (which is then approved by the NHS CCGs)